Blog · Vascular health

Clear medical information, without unnecessary jargon

Skin of the hands – Varices Barcelona
Picture of Dr. Marcello Barbosa

Dr. Marcello Barbosa

vascular surgeon

Let us discuss Raynaud's phenomenon. Upper-limb arterial disease is considered one of the more challenging areas of vascular practice. It is not only less common than lower-limb arterial disease, but also more complex, with a wide range of clinical manifestations and causes. Symptoms of ischaemia (inadequate blood supply) affecting the hands and fingers cause concern for both patients and clinicians. Patients worry about significant disability resulting from impaired hand function, while clinicians need to establish the correct diagnosis, ensure appropriate treatment and achieve the best possible outcome.
If the patient is found to have a primary vasospastic disorder (excessive vascular reactivity with vasospasm and no underlying disease), as in primary Raynaud's phenomenon, education and reassurance are central. Assessment and management become much more complex when a more serious underlying condition is identified.
Impaired arterial perfusion of the hands and fingers may result from obstruction of the larger proximal arteries, smaller arteries of the forearm or the microvasculature. Digital ischaemia may be episodic or persistent and may result from reversible vasospasm or fixed arterial occlusive disease. Symptoms range from cold hands and pale fingers to significant, irreversible tissue loss with digital ulceration, skin necrosis and gangrene.
The vascular specialist caring for patients with Raynaud's phenomenon must be familiar with a wide range of conditions, including thromboangiitis obliterans, connective tissue diseases, vasculitis and haematological disorders, as well as disorders specific to the upper limb such as thoracic outlet syndrome and occlusive arterial disease of occupational origin caused by vibration or trauma. A multidisciplinary approach is often necessary to ensure optimal care for these complex patients.

Raynaud's disease and Raynaud's phenomenon

In 1882, the French physician Maurice Raynaud presented his thesis to the Academy of Medicine entitled “On local asphyxia and symmetrical gangrene of the extremities”. In it, he described 25 patients with intermittent digital ischaemia and recognised the association of these episodes with local cold exposure and emotional stress. He attributed attacks of digital ischaemia to excessive sympathetic nervous system activity causing constriction of the digital arteries. He also described the classic three-phase skin colour changes, from digital pallor to cyanosis and then redness, now associated with his name. Patients with intermittent vasospastic episodes of digital ischaemia have been diagnosed as having “Raynaud's disease”.
Raynaud's original series included a mixture of patients. Some had primary vasospastic disease (excessive reactivity of the vessels in the hand to a trigger), whereas others with gangrene of the fingers probably had significant arterial obstruction. In 1901, Hutchinson recognised that Raynaud's observations could have several causes and coined the term Raynaud's phenomenon to indicate an underlying abnormality causing the disorder. For more than 100 years, patients with digital vasospasm have traditionally been classified into the following two groups according to the presence or absence of an associated condition:

  • The Raynaud's disease designation refers to a primary vasospastic disorder without an identifiable underlying cause.
  • The Raynaud's phenomenon designation refers to cases in which vasospasm is secondary to an underlying condition.

In clinical practice, the terms Raynaud's disease and Raynaud's phenomenon have not always been used consistently. They are often confused or used interchangeably and have consequently lost much of their original meaning. Reviewing the literature on Raynaud's is complicated by the lack of a universally accepted standard diagnostic classification.
For more than 20 years, John Porter and other authors have advocated replacing the older terms Raynaud's disease and phenomenon with Raynaud's syndrome.
Patients with Raynaud's syndrome can be divided into two groups: 1) primary Raynaud's, referring to vasospasm without an underlying cause, and 2) secondary Raynaud's, referring to patients with an underlying condition that causes the vasospastic episodes.
This classification is clinically useful because it highlights differences in pathology, treatment options and disease course between the two groups. When vasospasm is caused by another condition, the diagnosis should reflect that underlying disease (e.g. Buerger's disease with secondary Raynaud's phenomenon).
If a patient has significant arterial occlusive disease without features of vasospasm, they should not be labelled as having Raynaud's syndrome. Instead, the underlying condition, such as atherosclerosis, should be identified. Misuse of the term Raynaud's syndrome for all patients with fixed arterial occlusive disease has contributed to confusion and difficulties in assessing and treating upper-limb arterial disease. There are many examples of severe, irreversible hand-threatening ischaemia being incorrectly diagnosed as Raynaud's disease, delaying or leading to inappropriate treatment.

Raynaud's phenomenon: definition

Raynaud's phenomenon is defined as episodic pallor or cyanosis (bluish-purple discolouration) of the digits caused by constriction of the small digital arteries or arterioles in response to cold or emotional stress.
The characteristic feature of primary Raynaud's is a change in skin temperature and colour triggered by cold exposure. A typical vasospastic attack is characterised by sudden waxy pallor of part or all of one or more digits. Cyanosis then develops as blood within the capillaries becomes deoxygenated. The attack resolves when arterial blood flow returns and vasodilatation causes increased skin temperature and redness (Fig. 1).
Vasospastic attacks predominantly affect the fingers but may also affect the toes in up to a third of patients. Vasospasm of the nose, ears and even the nipples has been described, although it is uncommon.
Raynaud's phenomenon predominantly affects young women, but it may affect both sexes and occur at any age, including childhood. Older studies found that women were affected four times as often as men, whereas more recent surveys indicate that more men are affected, with a male-to-female ratio close to 1:1.678. Primary Raynaud's may begin between the ages of 11 and 45.

Varicose veins Barcelona – Raynaud's phenomenon

Fig. 1. The three phases of Raynaud's phenomenon: vasoconstriction, cyanosis and hyperaemia.

Prevalence of Raynaud's phenomenon

Raynaud's phenomenon is common. Prevalence is higher in colder climates, particularly in European countries such as England, Denmark and France. One study in England found that 8% of men and 17% of women experienced attacks of coldness, numbness and pale fingers. In a UK general practice setting, a postal questionnaire found Raynaud's phenomenon in 26 (11%) of 231 men and 34 (19%) of 182 women.

Diagnosis of Raynaud's phenomenon

Diagnosis is based on the patient's description of a typical vasospastic attack affecting one or more digits in association with cold exposure.
Coffman suggested the following diagnostic criteria for Raynaud's phenomenon: episodic attacks of well-demarcated pallor or cyanosis of one or more digits triggered by cold exposure or emotional stress.
Episodic means that attacks are reversible, in contrast to persistent ischaemia (inadequate blood supply). Local vasospasm causes a well-demarcated colour change, helping avoid overdiagnosis in people who simply have naturally pale fingers. By definition, vasospastic episodes are triggered by cold or emotional stress.
To diagnose Raynaud's phenomenon, all three colour changes do not need to be present.
Although the clinical presentation varies, a typical patient is a young woman who describes attacks of striking pallor affecting part or all of one or more fingers after cold exposure, followed by complete, rapid recovery on rewarming. Episodes are self-limiting and may last from less than a minute to more than 10 or 20 minutes. Local warming of the hands often helps resolve an attack. Pallor may affect part or all of a finger.
Attacks may occur several times a day or several times a week. Vasospastic episodes are more frequent during the colder winter months, and some patients have few or no attacks in summer.
Pain is not usually a feature during the pallor or cyanosis phase of primary Raynaud's. The absence of pain and tissue injury during vasospasm may be related to intermittent cold-induced vasodilatation during cooling and vasoconstriction, allowing sufficient blood flow to protect the digits from severe ischaemia or frostbite. Mild discomfort may occur during the hyperaemic recovery phase.
By contrast, patients with underlying occlusive disease (Raynaud's secondary to arterial obstruction) cannot adequately increase digital blood flow, so ischaemic injury may occur during cold exposure. Patients with secondary Raynaud's are more likely to experience digital pain during rewarming because blood flow cannot increase sufficiently to meet the increased metabolic demands of the tissue.

Why does primary vasospasm occur?

The cause of vasospastic attacks in primary Raynaud's remains unknown. No demonstrable structural abnormalities are found in the digital arteries. There is ongoing debate about whether primary Raynaud's represents an exaggerated normal thermoregulatory response causing digital vessel constriction during cooling, or a specific local or systemic defect.

Conditions associated with Raynaud's phenomenon

In most published series, at least a third of patients seeking initial assessment for Raynaud's have primary vasospasm without an identifiable cause. Among those with associated abnormalities, rheumatological disorders were the most frequent underlying conditions, accounting for 27% of cases of Raynaud's phenomenon. Scleroderma was the most likely condition, followed by undifferentiated and mixed connective tissue diseases. Atherosclerosis was less common, followed by hypersensitivity vasculitis, Buerger's disease, cancer and vibration white finger.
There is an extensive list of secondary causes of Raynaud's phenomenon (TABLE 1). These can be classified as connective tissue diseases (particularly scleroderma), large-vessel atherosclerotic disease and diabetic small-vessel disease, thromboangiitis obliterans, vasculitis, arterial embolism and atheroembolism. Conditions specific to the upper limb include arterial entrapment (thoracic outlet syndrome), occupational arterial disease including hypothenar hammer syndrome, vibration white finger and thermal injury to the digits. Drug- and toxin-induced vasospasm is also common. Finally, several systemic disorders increase blood viscosity and consequently promote vasospasm, as in cryoglobulinaemia and hepatitis-associated antigenaemia.

Varicose veins Barcelona – table
Table 1. Causes of secondary Raynaud's phenomenon.

Treatment of Raynaud's phenomenon

Management of Raynaud's should be individualised according to the patient's symptoms, frequency of vasospastic attacks, underlying condition and risk of ischaemic injury, gangrene or loss of digits. There is no cure for most patients with primary Raynaud's, although simple measures can reduce the frequency and duration of attacks. Education, reassurance, preventive measures and avoidance of cold exposure form the basis of management in most cases.
Treatment can be divided into three groups: non-pharmacological behavioural measures, drug treatment and interventional or surgical procedures.

Non-pharmacological treatments

Preventive measures
Most patients with Raynaud's have mild symptoms and do not require vasodilator medicines. A conservative programme focusing on keeping warm and avoiding triggers of arterial vasoconstriction is the most appropriate approach for these patients. Education and reassurance are central to management. Patients with primary Raynaud's (without an identifiable underlying cause) can be reassured that their condition has a low risk of progression to digital ulceration or loss of digits.
Patients should receive information about the nature and prognosis of primary Raynaud's, emphasising that the underlying arterial circulation is normal and that episodes of pallor and cyanosis reflect an exaggerated response of the digital arteries to cold exposure or emotional stress.
Simple measures to keep the hands warm and avoid cold can be quite effective. Protection from the cold may include wearing mittens rather than gloves in cold weather. Keeping the whole body warm is also important: if your body is warm, your hands are more likely to remain warm. Conversely, if you shiver, the body's natural response is to constrict peripheral blood vessels to conserve body heat. Room heating should be adjusted to a comfortable temperature above 21°C.
Patients should wear suitable warm clothing, including long sleeves. Chemical or electric hand warmers are available from outdoor and sports shops. Avoid or reduce situations that trigger vasospasm. Wear gloves when handling frozen foods or taking cold items from the fridge, and avoid immersing your hands in cold water. Warming the car before travelling helps prevent vasospasm from gripping a cold steering wheel. Riding a motorcycle on a cold day without protection can trigger attacks in many patients. Patients often notice attacks are more frequent in winter, and some choose to spend more time in warmer climates.
Avoiding triggers of vasoconstriction
The substance nicotine is a potent vasoconstrictor, and patients should be encouraged to stop using nicotine-containing products. Some over-the-counter medicines contain vasoconstrictors, such as slimming tablets containing stimulants like ephedrine. Beta-blockers, used to manage blood pressure and cardiac conditions, are a recognised cause of Raynaud's symptoms. Other medicines with vasoconstrictor properties include ergotamine preparations used for migraine, which may occasionally cause ergotism and marked vasospasm. Drugs of abuse such as cocaine and amphetamines may cause severe, potentially irreversible arterial constriction with permanent arterial damage.
Behavioural therapies and manoeuvres
Arm rotation: rotating the arms in a circular movement increases centrifugal force and arterial pressure in the hand and may help end a vasospastic attack.
 Temperature biofeedback: patients can learn to control autonomic functions such as skin temperature. By imagining a warm environment, for example lying on warm sand, they may learn to increase skin temperature voluntarily and reverse vasospastic episodes. Freedman reported benefits from biofeedback in 66% to 92% of patients with primary Raynaud's who mastered the technique. Training requires considerable time, up to 12 sessions of 45 minutes, as well as learning relaxation and meditation techniques.

Drug treatment

Drug treatment is indicated in patients with severe symptoms that affect daily activities and do not respond to simple conservative measures. Most people with mild or moderate symptoms respond to conservative treatment and do not need vasodilator medication. Some require medication only during the cold winter months, not during warmer summer months.
Doctors and patients often share frustration with drug treatment for Raynaud's phenomenon. Patients should understand that medicines may reduce the severity or frequency of vasospastic episodes, but do not cure the underlying cause of vasospasm and only 50% to 75% of patients respond to a particular medicine. Potential side effects and adverse consequences of medication must be balanced against the expected benefit.
Choosing the most suitable medicine is difficult because patients' responses and side effects vary. Examples of medicines used in Raynaud's phenomenon include:

  • Calcium channel blockers
  • α1-adrenoceptor blockers
  • Nitrates
  • ACE inhibitors

These are examples; your doctor will determine the most appropriate choice for your individual case.
Other therapies have shown promising results, such as acupuncture, transcutaneous electrical nerve stimulation, some antidepressants such as paroxetine, vasodilators such as cilostazol and sildenafil, and certain dietary supplements such as fish oil and L-arginine. In severe cases, intravenous medicines may also be used during hospital admission, such as prostaglandins.

Surgical treatment

Surgical management may involve reconstruction of occluded vessels when arterial obstruction is the underlying cause.
Digital sympathectomy of the hand and fingers has helped heal ulcers and relieve ischaemic pain. Its main indication is now non-healing wounds that are refractory to intensive medical treatment. Unfortunately, sympathectomy does not always provide lasting benefit. Initial improvement may be followed by recurrence due to nerve regeneration or progression of the underlying disease.
Raynaud's phenomenon is a clinical challenge involving several specialties and can lead to frustration and diagnostic errors. In our approach, it should be assessed and managed by a multidisciplinary team including vascular specialists, rheumatologists, internal medicine specialists, psychologists and potentially other professionals.

Related articles

Varicose vein specialist in Barcelona
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.